Share

October 2013; 3 (5) Cases

Simultaneous PML-IRIS and myelitis in a patient with neuromyelitis optica spectrum disorder

Eoin P. Flanagan, Allen J. Aksamit, Neeraj Kumar, Neha P. Morparia, B. Mark Keegan, Brian G. Weinshenker
First published September 6, 2013, DOI: https://doi.org/10.1212/CPJ.0b013e3182a78f82
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
156

Share

Article Information

vol. 3 no. 5 448-451
DOI: 
https://doi.org/10.1212/CPJ.0b013e3182a78f82
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published September 6, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Eoin P. Flanagan, MBBCh,
    2. Allen J. Aksamit, MD,
    3. Neeraj Kumar, MD,
    4. Neha P. Morparia, MD,
    5. B. Mark Keegan, MD and
    6. Brian G. Weinshenker, MD
  1. Eoin P. Flanagan, MBBCh,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Allen J. Aksamit, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Neeraj Kumar, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Neha P. Morparia, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. B. Mark Keegan, MD and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1)eMedicine Chief Editor 2009-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consulted for Bristol Myers Squibb, Novartis, and Bionest

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Terumo BCT, Caridian BCT

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Brian G. Weinshenker, MD
    7. Scientific Advisory Boards:

    1. (1) Novartis data safety monitoring board member (2) Biogen Idec data safety monitoring board member (3) Mitsubishi Pharmaceuticals data safety monitoring board member

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. 1. Canadian Journal of Neurological Sciences, editorial board member, 2006-present; no compensation 2. Turkish Journal of Neurology, editorial board member, 2005-present; no compensation 3. Multiple Sclerosis, editorial board member, 2010- present; no compensation

    Patents:

    1. 1) NMO-IgG for diagnosis of neuromyelitis optica; application 20050112116; patent issued and technology licensed to R.S.R. Ltd.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Elan Pharmaceuticals (2) GlaxoSmithKline Pharmaceuticals (3) Ono Pharmaceuticals (4) Asahi Kasei Medical Company

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Guthy Jackson Charitable Foundation, sponsor of research in NMO, 10/2008-09/2011

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NMO-IgG for diagnosis of neuromyelitis optica; patent issued and technology licensed to R.S.R. Ltd.

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology Mayo Clinic, Rochester, MN.
  1. Correspondence to:
    weinb{at}mayo.edu
View Full Text

Article usage

Article usage: September 2013 to August 2023

AbstractFullPdfSource
Sep 201338013Highwire
Oct 20131441630Highwire
Nov 2013126717Highwire
Dec 20138936Highwire
Jan 20142701Highwire
Feb 20142531Highwire
Mar 20143402Highwire
Apr 20143301Highwire
May 20143333Highwire
Jun 20141902Highwire
Jul 2014904Highwire
Aug 2014800Highwire
Sep 20141201Highwire
Oct 20141201Highwire
Nov 20142610Highwire
Dec 20142400Highwire
Jan 2015901Highwire
Feb 20151600Highwire
Mar 20152301Highwire
Apr 2015500Highwire
May 20151301Highwire
Jun 20152100Highwire
Jul 20151902Highwire
Aug 2015600Highwire
Sep 2015802Highwire
Oct 2015512Highwire
Nov 2015501Highwire
Dec 20151000Highwire
Jan 2016601Highwire
Feb 2016800Highwire
Mar 2016701Highwire
Apr 2016000Highwire
May 2016700Highwire
Jun 2016901Highwire
Jul 2016900Highwire
Aug 20161400Highwire
Sep 20161300Highwire
Oct 2016700Highwire
Nov 20161100Highwire
Dec 20163401Highwire
Jan 20171923Highwire
Feb 20171003Highwire
Mar 20171701Highwire
Apr 20171301Highwire
May 20171700Highwire
Jun 2017701Highwire
Jul 2017800Highwire
Aug 20171001Highwire
Sep 2017600Highwire
Oct 20171201Highwire
Nov 2017900Highwire
Dec 2017603Highwire
Jan 20181002Highwire
Feb 20181004Highwire
Mar 2018700Highwire
Apr 20182301Highwire
Apr 2018132pmc
May 20182704Highwire
Jun 20182911Highwire
Jun 2018056pmc
Jul 20181400Highwire
Aug 2018800Highwire
Aug 2018176pmc
Sep 20181302Highwire
Oct 20181100Highwire
Nov 2018700Highwire
Dec 20181622Highwire
Jan 2019510Highwire
Feb 2019500Highwire
Mar 2019501Highwire
Apr 2019801Highwire
May 2019920Highwire
Jun 2019900Highwire
Jul 2019300Highwire
Aug 2019200Highwire
Sep 2019600Highwire
Oct 2019700Highwire
Nov 20191001Highwire
Dec 2019600Highwire
Jan 2020500Highwire
Feb 20201200Highwire
Mar 2020600Highwire
Apr 2020400Highwire
May 20202100Highwire
Jun 2020900Highwire
Jul 20201201Highwire
Aug 2020900Highwire
Sep 2020801Highwire
Oct 20201211Highwire
Nov 2020300Highwire
Dec 2020700Highwire
Jan 2021800Highwire
Feb 2021700Highwire
Mar 2021600Highwire
Apr 2021910Highwire
May 2021400Highwire
Jun 2021500Highwire
Jul 20211200Highwire
Aug 20211901Highwire
Sep 2021500Highwire
Oct 20213000Highwire
Nov 2021600Highwire
Dec 20211710Highwire
Jan 2022900Highwire
Feb 20221700Highwire
Mar 20221300Highwire
Apr 20221100Highwire
May 2022900Highwire
Jun 2022500Highwire
Jul 2022702Highwire
Aug 2022700Highwire
Sep 20221600Highwire
Oct 20221100Highwire
Nov 20224701Highwire
Dec 20221300Highwire
Jan 20232101Highwire
Feb 20231100Highwire
Mar 2023501Highwire
Apr 2023501Highwire
May 2023901Highwire
Jun 2023902Highwire
Jul 20231200Highwire
Aug 2023700Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles